What is the recommended evaluation and treatment approach for acute aggression in adults and older adults?

Management of Acute Aggression in Adults and Older Adults

For acute agitation in the emergency department, attempt verbal de-escalation first, then administer either intramuscular lorazepam 2–4 mg or intramuscular haloperidol 5 mg, with both agents showing equivalent efficacy for rapid control of aggressive behavior. 1

Initial Assessment and Safety

Before initiating pharmacologic intervention, prioritize verbal and behavioral de-escalation techniques to avoid medication-related adverse effects. 1

Conduct a focused evaluation to identify reversible medical causes:

• Rule out anticholinergic or sympathomimetic drug intoxication, as antipsychotics may worsen agitation in these scenarios due to their anticholinergic properties 1
• Assess cognitive function rather than waiting for specific blood alcohol levels—if the patient is alert with appropriate cognition, normal vital signs, and noncontributory examination, begin psychiatric assessment immediately 1
• Evaluate for head trauma, neurological deficits, endocrine disorders (diabetes, hyperthyroidism), and infectious causes 1
• Assess cardiopulmonary status and identify any physical characteristics that may affect restraint safety 1

Obtain critical history elements:

• Prior aggressive behaviors, including homicide, domestic violence, workplace violence, or other physically/sexually aggressive acts 1
• History of violent behaviors in biological relatives 1
• Exposure to violence, combat, or childhood abuse 1
• Legal or disciplinary consequences of past aggression 1
• Specific triggers such as psychosocial stressors, trauma history, or substance use 1

Acute Pharmacologic Management

First-Line Options for Rapid Tranquilization

Benzodiazepines are as effective as haloperidol for acute agitation:

• Lorazepam 2–4 mg intramuscularly demonstrates equivalent efficacy to haloperidol 5 mg in multiple Class II studies 1
• Benzodiazepines carry lower risk of extrapyramidal symptoms compared to first-generation antipsychotics 1

Haloperidol has the strongest evidence base among conventional antipsychotics:

• Administer 5 mg intramuscularly for acute agitation 1
• Monitor for extrapyramidal symptoms and akathisia, which can paradoxically worsen agitation 1

Second-generation antipsychotics offer similar efficacy with better tolerability:

• Intramuscular olanzapine 10 mg is recommended for agitation in schizophrenia or bipolar mania, with lower doses (5–7.5 mg) considered when clinical factors warrant 2
• Subsequent doses up to 10 mg may be given if agitation persists, but doses should be spaced at least 2 hours apart (4 hours after the second dose) 2
• Critical safety warning: Assess for orthostatic hypotension before administering subsequent intramuscular olanzapine doses, as maximal dosing (three 10-mg doses) is associated with substantial orthostatic hypotension 2
• Do not exceed 30 mg total daily dose 2

Transition to Oral Therapy

Once acute agitation resolves, transition to oral olanzapine 5–20 mg/day as soon as clinically appropriate. 2

Management of Persistent Aggression

Diagnostic Reassessment

When aggression persists despite acute management, systematically evaluate for underlying psychiatric disorders:

• Schizophrenia or other psychotic disorders 1
• Bipolar disorder or mood dysregulation 1
• Substance use disorders, particularly alcohol or stimulant intoxication/withdrawal 1
• Personality disorders, especially antisocial or borderline types 3, 4
• Cognitive impairment or dementia 3, 5
• Post-traumatic stress disorder with trauma-related rage triggers 1

Long-Term Pharmacologic Strategies

For schizophrenia with persistent aggression, clozapine is the preferred agent due to superior antipsychotic efficacy and specific anti-hostility effects. 5

For aggression without comorbid psychotic disorder, consider lithium or propranolol as first-line chronic management:

• Both agents have extensive clinical experience and research support 4
• Trial duration should be 6–8 weeks at maximum tolerated doses before assessing efficacy 4

Mood stabilizers are effective for impulsivity-driven aggression:

• Valproate may be helpful for poor impulse control and personality disorders 5
• Carbamazepine is an alternative option 4

Additional agents with documented efficacy:

• Beta-blockers (propranolol) for chronic aggression 5, 4
• Buspirone or trazodone for anxiety-related aggression 4
• SSRIs for aggression with comorbid depression 4

Behavioral and Environmental Interventions

Implement structured behavioral strategies alongside pharmacotherapy:

• Token economy systems create a well-structured milieu and are the most comprehensive behavioral tool 3
• Aggression replacement training teaches alternative responses to triggers 3
• Decelerative techniques enable rapid reduction of aggressive impulses 3

Provide psychoeducation on trigger identification, self-directed time-outs, distraction techniques, and assertive communication. 1, 6

Critical Pitfalls to Avoid

Never use benzodiazepines for chronic aggression management—they cause paradoxical rage reactions, dependence, and cognitive impairment. 6, 7, 4

Do not combine multiple antipsychotics or mood stabilizers without adequate single-agent trials—systematically trial one medication class for 6–8 weeks at therapeutic doses before switching or adding agents. 6, 8

Avoid immediate debriefing after an aggressive incident—allow time for psychological recovery before discussing the event. 6

Do not stereotype patients as dangerous based on race or culture—assess individual risk factors systematically. 1, 7

Monitoring and Follow-Up

Re-evaluate patients every 3–6 months when on chronic anti-aggression pharmacotherapy, and attempt periodic medication tapers or drug-free periods. 4

Use standardized aggression rating scales (Overt Aggression Scale, Brief Psychiatric Rating Scale) to track treatment response at baseline, 4 weeks, 8 weeks, and end of treatment. 6, 7

Maintain consistent communication among emergency, inpatient, outpatient, and family systems to ensure uniform implementation of management strategies. 6